Go to the scene: TH9 cells superior migration ability to the lungs explains their exceptional anticancer efficacy
Antibodies against immune checkpoints are now routinely administered as a first line of treatment against metastatic lung cancer. Resistance to immune checkpoint inhibitors is, however, frequent, underscoring the need to find alternative treatments. A…